Endometriosis
Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more
Award winning not-for-profit scoops further endorsement to tackle health inequalities and improve health and wellbeing.
Nottinghamshire residents are set to benefit from improved access to complementary health services, thanks to a development grant from Futurebuilders England.
Social enterprise Impact Integrated Medicine Partnership provides complementary health services including acupuncture, chiropractic and homeopathy to patients with long-term conditions.
Since 2004 Impact has treated over 300 people, tackling health inequalities and reducing NHS costs of longer-term care and treatment. After completing an Impact programme, 87% of patients report reducing or stopping their prescribed medication; 76% visit their GP less frequently; and a number no longer require hospital treatment such as physiotherapy or spinal injections.
After winning the 2006 NHS Alliance Acorn Award for Integrated and Complementary Healthcare, Impact is now working with local GPs, Nottingham City PCT, and Nottinghamshire Healthcare NHS Trust to develop complementary services for more NHS patients. This will primarily be through the new practice-based commissioning initiative within the NHS.
A £12,145 development grant from Futurebuilders will support Impact’s business planning and marketing, as well as strengthen the organisation’s capacity as it works towards gaining additional contracts with the public sector. Impact has a good track record of working with hard-to-reach groups and the development grant will support the wider roll-out of this work.
Julie McKay, Director of Impact said: “We are delighted to be receiving support from Futurebuilders England. We know the Government is keen to encourage third sector healthcare providers to enter the NHS, and we are working hard with commissioners to introduce new types of treatment and more choice for patients.
“There is a high demand for complementary health services within the NHS. Nearly 1,000 local people have signed a petition calling for acupuncture, chiropractic and homeopathy to be made available as part of their NHS treatment. We’re looking forward to developing our work in the NHS and with other public sector organisations, so that many more people across Nottingham can benefit from this type of care.”
Richard Gutch, Chief Executive of Futurebuilders England said: “We are thrilled to be supporting Impact to develop their complementary medicine programme. Social enterprises are leading the way in the delivery of innovative public services and Impact has shown us how a joined up approach to healthcare can help many people lead healthier and more rewarding lives.”
Suzanne Topham, Impact patient said: “When I first came to Impact I was on anti-depressants and knew nothing about homeopathy. My doctor said I’d need to be on medication for at least six months, but I was able to safely stop taking it three months after starting at Impact. It’s helped me get back to a normal life. What we need now is for the NHS to provide these services all over the country.”
Ends
For further information please contact Jayna Danckert at Futurebuilders England on 0207 927 6346 or Fiona Robertson at Impact Integrated Medicine Partnership on 07879 686285.
Notes to editor
About Impact Integrated Medicine Partnership
About Futurebuilders England
Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more
Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more
Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more
The DoH will change the contract to allow correction factors to be cut legally, the GPC announced ye... Read more
GPC negotiator Dr Stewart Drage has revealed he has become a woman. Read more
Nursing unions have called for the Nursing and Midwifery Council (NMC) to appoint an external candid... Read more
Capita, the UK's leading outsourcing company, is the DoH's preferred bidder for the NHS Choices cont... Read more
Every hospital emergency department in England should share information about violent incidents with... Read more
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more
Comments
Only registered users may comment. Log in now or register for a free account.